Banafshé Larijani

8PUBLICATIONS
5CO-AUTHORS
Innate immunityPredictive and prognostic markersMolecular targetsCell and nuclear divisionToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 24, 2022
The fusion of quantitative molecular proteomics and immune-oncology: a step towards precision medicine in cancer therapeutics.

James Miles, Stephen G Ward, Banafshé Larijani

|Mar 16, 2021
Quantification of biomarker functionality predicts patient outcomes.

Banafshé Larijani, James Miles, Stephen G Ward

|Aug 29, 2020
High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment.

Lissete Sánchez-Magraner, James Miles, Claire L Baker

|Apr 24, 2020
Tandem NMR and Mass Spectrometry Analysis of Human Nuclear Membrane Lipids.

Régine Dazzoni, Corinne Buré, Estelle Morvan

|Oct 12, 2019
A Complex Interplay of Anionic Phospholipid Binding Regulates 3'-Phosphoinositide-Dependent-Kinase-1 Homodimer Activation.

Gloria de Las Heras-Martínez, Véronique Calleja, Remy Bailly

|Sep 25, 2019
Lipid species affect morphology of endoplasmic reticulum: a sea urchin oocyte model of reversible manipulation.

Gabriela Ulloa, Fadi Hamati, Alexander Dick

Pageof 2

Frequent Collaborators

1 joint publications

Jose Requejo-Isidro

1 joint publications

Antoine Loquet

1 joint publications

Shaimaa Lashin

1 joint publications

Andrew G Watts